A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS
Clinical trial NCT01149057 · COMPLETED
Trial details
- NCT number
- NCT01149057
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-07-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.